Insulet Corporation

(NASDAQ: PODD) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 150,000 insulin-dependent diabetics are using it worldwide.

Contact Information

Website: www.insulet.com
Email: dgordon@insulet.com
Main Phone: +1 978 600-7000
Address: 100 Nagog Park
Address 2: Suite 200
State: MA
City / Town: Acton
Country: US
Postal Code: 01720

Issuer Information

Exchange: NGS
CEO: Shacey Petrovic
Employees: 1900
NAICS: Surgical and Medical Instrument Manufacturing(339112)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A